Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib was effective for severe, treatment-resistant hair loss without side effects.

P311 helps skin stem cells become myofibroblast-like cells, aiding wound healing.

Baricitinib significantly regrows hair in severe alopecia areata patients.

Upadacitinib effectively improved severe atopic dermatitis and alopecia universalis in a 29-year-old man.

Topical ruxolitinib and oral minoxidil together can regrow hair in certain types of hair loss.

Baricitinib helps treat severe hair loss in people over 65.

Teicoplanin may help treat hair loss by reducing androgen receptors and boosting hair cell growth.

Tofacitinib is effective and safe for treating alopecia areata.

Normal human melanocytes can avoid cell death through multiple pathways.

Patients with alopecia areata using Janus kinase inhibitors are not following lab monitoring guidelines.

Patients were very satisfied with hair regrowth after taking ritlecitinib for alopecia areata.

The research found a way to develop hair growth materials by targeting a specific signaling pathway.

Abrocitinib effectively treated severe atopic dermatitis and mild alopecia areata in a 12-year-old boy after dupilumab failed.

EGFR inhibitors can cause skin issues, but managing them is important for treatment success.

Stopping mitochondrial respiration can prevent brain cancer spread in skin cancer patients, and plant compound β-sitosterol could help achieve this.

Minoxidil and ranolazine together can reduce the spread of certain breast cancer cells.

EGFR cancer drugs often cause a rash, which can lead to distress and isolation, but may also improve outcomes for some cancer patients. Current treatments for the rash are limited, but a compound called menadione shows promise.

JAK inhibitors are effective and safe for treating severe alopecia areata.

Using CDK inhibitors on rats showed a reduction in chemotherapy-caused hair loss, but later experiments could not repeat these results.

Baricitinib can cause excessive hair growth.

New treatment with green tea polyphenols and nicotinamide improves skin problems from cancer therapy.

All-trans-retinoic acid stops mink hair growth by affecting cell growth and causing cell death.

A patient with Alopecia Areata had complete hair regrowth after using the drug baricitinib.

Ritlecitinib is effective and safe for treating alopecia areata, promoting significant hair regrowth.

Semecarpus anacardium leaf extracts may offer safe, effective cancer treatment alternatives.

Verteporfin reduces growth and stem cell traits in rat hair follicle cells by blocking the Hippo pathway.

Ritlecitinib effectively regrows eyebrow and eyelash hair in alopecia areata, with 50 mg being the best dose.

New melanoma treatments can cause skin side effects, including skin cancer and rashes, but combining treatments may reduce these risks.

The article concludes that hair loss is a common side effect of drugs treating skin cancer by blocking the hedgehog pathway, but treatment should continue, and more selective drugs might prevent this side effect.

JAK inhibitors show promise for treating skin conditions like eczema, hair loss, and psoriasis.